Henry Schein to announce Q2 2026 results on August 4

1 min read     Updated on 21 Jul 2026, 04:54 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Henry Schein will release its Q2 2026 financial results before the market opens on August 4, 2026, followed by a live webcast at 8:00 a.m. ET. CEO Fred Lowery and CFO Ronald N. South will host the call, accessible via the company's investor relations website.

powered bylight_fuzz_icon
46178671

*this image is generated using AI for illustrative purposes only.

Henry Schein, Inc. will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026. The company will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer.

Investors can access the call by visiting the Henry Schein investor relations website. A replay of the presentation will be available on the Henry Schein website following the event.

Key Event Details

Event Details
Financial Period Second Quarter 2026
Results Release Before market open, August 4, 2026
Conference Call 8:00 a.m. ET, August 4, 2026
Webcast Access investor.henryschein.com/webcasts

About Henry Schein

Henry Schein, Inc. is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the company's network of trusted advisors provides more than 1 million customers globally with over 300 valued solutions. These solutions help improve operational success and clinical outcomes for office-based dental and medical practitioners, dental laboratories, government and institutional healthcare clinics, and other alternate care sites.

The company operates through a centralized and automated distribution network, offering a selection of more than 300,000 branded products and Henry Schein corporate brand products. A FORTUNE 500 Company and a member of the S&P 500 index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The company's sales reached $13.2 billion in 2025.

How will Henry Schein's Q2 2026 performance compare to industry trends in healthcare distribution?

What strategic initiatives might management highlight during the call to drive future growth?

Could the results signal any shifts in demand for dental and medical products globally?

like15
dislike

BMO Capital initiates coverage on Henry Schein with $85 price target

0 min read     Updated on 09 Jul 2026, 11:02 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

BMO Capital initiates coverage on Henry Schein with a Market Perform rating and a price target of $85.

powered bylight_fuzz_icon
45163923

*this image is generated using AI for illustrative purposes only.

BMO Capital has initiated coverage on Henry Schein with a Market Perform rating and a price target of $85. The rating reflects a neutral outlook on the stock's performance potential.

Coverage Details

The research note provides an initial assessment of Henry Schein's market position. The price target of $85 serves as a benchmark for the stock's valuation.

Metric Value
Rating Market Perform
Price Target $85

What specific market factors could drive Henry Schein's stock above the $85 price target?

How might recent changes in the healthcare supply chain impact Henry Schein's future performance?

What are the potential risks that could lead BMO Capital to revise its Market Perform rating?

like19
dislike

More News on Henry Schein Inc